Global Biopharmaceutical Contract Manufacturing Market
Overview:
Contract manufacturing organizations (CMOs) are companies that provide drug development and drug manufacturing services to pharmaceutical and biotechnology industries on a contract basis. Biopharma companies prefer contract manufacturing organizations due to the complexity in the manufacturing process of biomolecules, because they consist of different size, shape and behavior with a much more complex process than pharmaceutical drugs. CMOs also provide cell line development, process optimization, fermentation, and analytical characterization.
Drivers:
The escalating importance of CMOs in the field of biotechnology is expected to boost growth of the global biopharmaceutical contract manufacturing market over the forecast period.
Market players are adopting various strategies, such as facility expansion, to strengthen their market position. For instance, in January 2020, Celltrion Group announced plans to build its first overseas biopharmaceutical factory in Wuhan, Hubei Province, China with an investment of over US$ 500 million. The new factory will have a capacity around 60% of that, at 120,000 liters. The company aims to expand its overall production capacity to 1 million liters by 2030.
๐๐จ ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐จ๐ฏ๐ข๐๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/1077
Moreover, market players are focusing on merger and acquisition to strengthen their market position or to expand their product portfolio. This in turn is also expected to propel growth of the market. For instance, in January 2020, Cognate BioServices announced that the company has completed the acquisition of Cobra Biologics. With this acquisition, Cognate BioServices will provide drug development & manufacturing solutions to the cell and gene immunotherapy and regenerative medicine industries worldwide.
In August 2019, Patheon and Royal DSM completed merger to form private company DPx in a US$ 2.65 billion deal that analytes believe has created the worldโs second biggest CMO.
Furthermore, in January 2020, Indapta Therapeutics and Lonza teamed up to advance a next-generation, off-the-shelf, allogeneic immuno-oncology therapy.
Technological advancement or increasing use of advanced technologies is also expected to aid in the growth of the global biopharmaceutical contract manufacturing market over the forecast period. Market player are using advanced technologies such as Artificial Intelligence (AI) to manufacture biologics. For instance in December 2019, iBioPharma Inc. announced that it has entered into a collaboration with EdgePoint AI for next gen quality in biologics manufacturing. Advanced technologies are expected to lower the operating costs and improve the quality of biologics contract development and manufacturing services.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ง๐ ๐๐๐ญ ๐ ๐ฅ๐๐ญ ๐๐% ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/insight/buy-now/1077
Moreover, in October 2019, Mesoblast and Lonza teamed up to manufacture Mesoblastโs lead allogeneic (off-the-shelf) cell therapy product candidate, remestemcel-L for pediatric steroid-refractory acute graft versus host disease (aGVHD). This agreement will facilitate inventory build ahead of the planned United States (US) market launch of remestemcel-L and commercial supply to meet Mesoblastโs long-term market projections.
Competitive Landscape:
Key players active in the global biopharmaceutical contract manufacturing market are Sandoz, Celonic GmbH, BIOMEVA GmbH, Boehringher Ingelheim, ProBioGen AG, Lonza Group Ltd., Rentschler Biotechnologie, and Fujifilm Diosynth Biotechnology, among others.
Market Taxonomy:
By Contract Type:
- Active Pharmaceutical Ingredient (API)
- Fill-And-Finished
By Product Type:
- Interferons
- Monoclonal Antibodies
- Recombinant Hormone
- Proteins
- Vaccines
- Vitamins
- Insulin
By Therapeutic Applications:
- Oncology
- Autoimmune Diseases
- Metabolic Diseases
- Cardiovascular Diseases
- Neurology
- Infectious Diseases
By Region:
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East
- Africa
๐๐จ ๐๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐๐ซ๐ @ https://www.coherentmarketinsights.com/insight/request-pdf/1077
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837